Study of neoadjuvant chemotherapy for invasive bladder cancer with MEC (methotrexate, epirubicin, cisplatin) therapy

Eighteen patients with locally invasive bladder cancer were treated with 1 or 2 cycles of neoadjuvant chemotherapy consisting of methotrexate, epirubicin and cisplatin (MEC). All patients underwent radical cystectomy and pelvic lymph node dissection. Down-staging was observed in twelve (complete pat...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 47(2001), 4 vom: 24. Apr., Seite 241-6
1. Verfasser: Ohuchi, H (VerfasserIn)
Weitere Verfasser: Noguchi, S, Takase, K, Kawakami, S, Ikeda, I, Saito, K, Yao, M, Masuda, M, Kubota, Y, Hosaka, M
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2001
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Epirubicin 3Z8479ZZ5X Cisplatin Q20Q21Q62J Methotrexate YL5FZ2Y5U1
Beschreibung
Zusammenfassung:Eighteen patients with locally invasive bladder cancer were treated with 1 or 2 cycles of neoadjuvant chemotherapy consisting of methotrexate, epirubicin and cisplatin (MEC). All patients underwent radical cystectomy and pelvic lymph node dissection. Down-staging was observed in twelve (complete pathological response in 3 and partial pathological response in 9) patients (response rate were 67%). Four of the 18 patients died of disease and all of them had not achieved down-staging. Multivariate analysis revealed nodal status to be the only independent predictor. With regard to side effects, gastrointestinal symptoms and myelo-suppression were observed in almost all patients. Thrombocytopenia was observed in 13 patients (72%) including 7 patients who showed symptoms over grade 3. Gastro-intestinal symptoms and leukocytopenia disappeared with granisetron and granulocyte colony stimulating factor. There were no treatment-related deaths in this study. These results indicate that MEC therapy was safely performed and showed a high response rate in patients with locally invasive bladder cancer
Beschreibung:Date Completed 12.07.2001
Date Revised 21.11.2013
published: Print
Citation Status MEDLINE
ISSN:0018-1994